<a href="https://laohu8.com/S/ATOM">Atomera Inc</a> reports second quarter 2025 results with revenue of 4 thousand dollars
Atomera Inc. reported a net loss of $5.0 million in the second quarter of 2025, compared to a net loss of $4.4 million in the second quarter of 2024. Adjusted EBITDA for the second quarter of 2025 was a loss of $4.0 million, compared to a loss of $3.6 million in the same period of 2024. Cash and cash equivalents were $22.0 million as of June 30, 2025, compared to $25.8 million as of December 31, 2024. Total shares outstanding were 31.1 million as of June 30, 2025. Revenue for the second quarter of 2025 was $4,000, while cost of revenue was $62,000, resulting in a gross margin of negative $58,000. Operating expenses were $5.2 million for research and development, $2.0 million for general and administrative, and $0.1 million for selling and marketing, totaling $5.2 million. Loss from operations was $5.2 million. Other income (expense), net, was $288,000 for the quarter.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atomera Inc. published the original content used to generate this news brief on October 07, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.